About Critical Path Institute
Lead collaborations that accelerate drug development, advancing better treatments for people worldwide by generating solutions and tools through pre-competitive, multi-stakeholder partnerships.
Focus Areas
Neuroscience (Alzheimer's, Parkinson's, rare neurodegenerative diseases)Rare and Orphan DiseasesPediatricsBiomarkers and biomarker qualificationClinical outcome assessment (COA/eCOA)Modeling & simulation / quantitative medicineData platforms and repositories (RDCA-DAP)Regulatory science and trainingTranslational therapeutics / drug acceleration
Who They Fund
patients with rare and other high‑need diseasespeople with neurodegenerative diseases
About Critical Path Institute
Critical Path Institute uses subawards to move drug development projects from preclinical work toward clinical testing, often through collaborations built around translational therapeutics, regulatory science, and biomarker work. Its recent grants show a pattern of funding large research institutions and specialized medical organizations rather than individuals. The National Organization for Rare Disorders received the largest award in the recent list, at $1,964,277 in 2025, following prior awards of $1,604,706 in 2023 and $1,517,664 in 2024. Society of Critical Care Medicine also appears repeatedly, with $1,377,667 in 2024 and $835,334 in 2023, indicating sustained support for a single organizational partner across multiple years. The foundation’s funding aligns with its stated emphasis on neuroscience, rare and orphan diseases, pediatrics, biomarkers, clinical outcome assessment, modeling and simulation, and data platforms. Recent recipients include Emory University, Johns Hopkins University, Yale University, and the University of Arizona, reflecting a mix of academic medical centers and research consortia. Leadership is listed under Dr. Klaus Romero, and the organization’s public programs include BRIDGe, TRxA BRIDGe Awards, and an RFP portal for collaborations and projects.
What Critical Path Institute Funds
Rare and orphan diseases are a clear thread in the grant record. The National Organization for Rare Disorders received $1,964,277 in 2025, along with earlier subawards of $1,604,706 in 2023 and $1,517,664 in 2024, showing repeated support for work tied to rare-disease infrastructure and coordination. Pediatrics also appears in the grant list through the Institute for Advanced Clinical Trials for Children, which received $137,738 in 2023 and $77,657 in 2024. That pattern fits a funder focused on advancing clinical development tools and trial capacity for high-need patient groups. In neuroscience, the foundation backed the University of California with $347,500 in 2025, while other awards reached Yale University, Northwestern University, and the University of Rochester. These grants sit alongside its stated focus on Alzheimer’s, Parkinson’s, and rare neurodegenerative diseases, as well as biomarkers and clinical outcome assessment.
How Critical Path Institute Gives
Typical award sizes sit in a mid-six-figure band, with a p25 of $82,818, a median of $135,306, and a p75 of $339,196. The recent grant list shows both very large subawards and smaller research awards, so the portfolio is spread across a wide range. The same recipients often appear across multiple years, which points to recurring relationships rather than one-off grants. Examples in the data include the National Organization for Rare Disorders, Society of Critical Care Medicine, Emory University, Johns Hopkins University, Yale University, University of Arizona, University of Rochester, Tufts Medical Center, and the Institute for Advanced Clinical Trials for Children. The foundation is not an individual-giving funder and does not make program-related investments. Its public mechanisms include BRIDGe, TRxA BRIDGe Awards, and an RFP portal, all of which accept unsolicited proposals.
Financial Snapshot
Annual Giving
$3.8M
Total Assets
$38.4M
Total Revenue
$46.8M
Total Expenses
$40.2M
Typical Grant Size
Most grants fall between $83K and $339K, with a median of $135K.
25th Percentile
$83K
Median
$135K
75th Percentile
$339K
Geographic Reach
National13 states funded
About 5% of grants go to recipients in MD.
Funding intensity
LowHigh
Headquarters
Leadership
DR KLAUS ROMERO
Unlock Deep Analysis
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeSee Similar Funders
Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeExplore related grant guides
Want a Personalized Pitch for Critical Path Institute?
Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Free plan available
No contracts
Cancel anytime